Latest In


How Pharm Companies Used Psychiatrists to Push Amphetamines

Psychiatrists may make a fortune administering drugs. They aren't compensated to prescribe, while pharma firms are no longer allowed to send extravagant gifts, they may still pay for physicians and their families to attend “meetings” in exotic and attractive destinations.

Author:Suleman Shah
Reviewer:Han Ju
Oct 11, 202225 Shares409 Views
Amphetamines are psychostimulant medicines, which means they accelerate the transmission of information between the brain and the body. Doctors use some forms of amphetamines to treat illnesses such as attention deficit hyperactivity disorder (ADHD) and narcolepsy (where a person has an uncontrollable urge to sleep).
Parkinson's disease has also been treated using amphetamines. Other amphetamines, such as speed, are manufactured and marketed illegally. Amphetamines have also been used as a performance enhancer. Crystal methamphetamine is the most powerful type (ice).
In the present pandemic of depression and hyperactivity, the psychiatric profession and huge pharmaceutical companies have played a role in spreading misinformation about the diseases. The most often asked question these days is whether or not psychiatry has any credibility left at all.
Failed physicians go on to become psychiatrists, while failed psychiatrists go on to specialize in pharmaceuticals. The psychiatrist was referring to drugs of addiction, and the therapyconsisted of prescribing Temgesic, a synthetic opioid, as a substitute for heroin, which patients were more likely to consume as a result.
In response, psychiatrists took on this job, in effect functioning as a state-licensed drug salesman; he also undertakes a form of psychotherapy, speaking with the patient about his or her difficulties and participating in his or her own restless critique of psychiatry, among other things.

Top 10 Most Abused Prescription Drugs

Do Psychiatrists Push Medication?

As pill-pushers, psychiatrists are unsatisfied since the most intriguing element of treatment is gaining a thorough grasp of each patient's psychodynamics and assisting the patient in gaining insight into his or her behaviour."
In the public eye, psychiatrists are seen as "pill pushers," and larger insurance payments for medications versus talk therapy have certainly contributed to a rise in prescription practises. Although psychiatrists share part of the responsibility for this reputation, they also hold some of the responsibility.

Do Psychiatrists Make Money Off Prescriptions?

Psychiatrists, especially academic psychiatrists, may make a fortune administering drugs. Of course, they aren't compensated to prescribe. While pharma firms are no longer allowed to send extravagant gifts, they may still pay for physicians and their families to attend “meetings” in exotic and attractive destinations.
Psychiatrists can also work as drug company main investigators. That is, they supposedly undertake drug research that leads to FDA approval or novel uses for pharmaceuticals currently approved. The “principal investigator” of a drug study may not even know the name of the medication being studied (in extreme cases), because the study is really run by the drug company, which then uses the physician's name as “principal investigator” and uses the University's name to gain prestige.
Not only do psychiatrists profit from drug prescriptions, but they tend to be the worst. Dr. Marcia Angell, the former editor of The New England Journal of Medicine, believes the pharmaceutical business spends a lot of money on the ‘education' of doctors.

Do Psychiatric Medications Cause More Harm Than Good?

One of the world's finest clinical trial experts says in a renowned medical publication that psychiatric pharmaceuticals cause more damage than help and that the usage of most antidepressants and dementiatreatments could be practically eliminated without harming patients.
The issue over the use of psychiatric medicines is crucial, and it is acknowledged that antipsychotics have been overused to calm violent dementia patients who are becoming increasingly hostile. The results of pharmacological studies for schizophrenia have likewise been dismal, while the results of trials for ADHD (attention deficit hyperactivity disorder) are still up in the air.
The short-term benefits appear to have been supplanted by long-term negative consequences. Animal studies clearly show that these medicines are capable of causing brain damage, which is likely to be the case for all psychotropic medications.
Long-term usage of schizophrenia medications appeared to minimise the number of early deaths; but, in practise, regular evaluations of treatments between a patient and their psychiatrist are required in order to continuously assess the advantages and disadvantages of any given treatment.


Over the last two centuries, the field of psychiatry has been plagued with "treatments" and "cures" that have later been shown to be severely damaging. It goes on and on, from mesmerization and lobotomyto electroconvulsive treatment, Valium, and other benzodiazepines - the list of these abominations is lengthy and ignoble, and I have no doubt that the Selective serotonin reuptake inhibitors (SSRIs) will soon be added to the list.
We will all have to wake up one day, smell the snake oil, and realise that although medical sciencehas provided us with infinite benefits, medical pseudo-science has shown to be just as capable of progress. As it turns out, heroin was one of the substances that Irving Kirsch's meta-analysis of antidepressant studies discovered to be just as effective as the standard antidepressant medications.
Jump to
Suleman Shah

Suleman Shah

Suleman Shah is a researcher and freelance writer. As a researcher, he has worked with MNS University of Agriculture, Multan (Pakistan) and Texas A & M University (USA). He regularly writes science articles and blogs for science news website and open access publishers OA Publishing London and Scientific Times. He loves to keep himself updated on scientific developments and convert these developments into everyday language to update the readers about the developments in the scientific era. His primary research focus is Plant sciences, and he contributed to this field by publishing his research in scientific journals and presenting his work at many Conferences. Shah graduated from the University of Agriculture Faisalabad (Pakistan) and started his professional carrier with Jaffer Agro Services and later with the Agriculture Department of the Government of Pakistan. His research interest compelled and attracted him to proceed with his carrier in Plant sciences research. So, he started his Ph.D. in Soil Science at MNS University of Agriculture Multan (Pakistan). Later, he started working as a visiting scholar with Texas A&M University (USA). Shah’s experience with big Open Excess publishers like Springers, Frontiers, MDPI, etc., testified to his belief in Open Access as a barrier-removing mechanism between researchers and the readers of their research. Shah believes that Open Access is revolutionizing the publication process and benefitting research in all fields.
Han Ju

Han Ju

Hello! I'm Han Ju, the heart behind World Wide Journals. My life is a unique tapestry woven from the threads of news, spirituality, and science, enriched by melodies from my guitar. Raised amidst tales of the ancient and the arcane, I developed a keen eye for the stories that truly matter. Through my work, I seek to bridge the seen with the unseen, marrying the rigor of science with the depth of spirituality. Each article at World Wide Journals is a piece of this ongoing quest, blending analysis with personal reflection. Whether exploring quantum frontiers or strumming chords under the stars, my aim is to inspire and provoke thought, inviting you into a world where every discovery is a note in the grand symphony of existence. Welcome aboard this journey of insight and exploration, where curiosity leads and music guides.
Latest Articles
Popular Articles